A detailed history of Wolverine Trading, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Wolverine Trading, LLC holds 206,099 shares of AUPH stock, worth $1.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
206,099
Holding current value
$1.84 Million
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.32 - $7.33 $1.1 Million - $1.51 Million
206,099 New
206,099 $1.51 Million
Q2 2023

Aug 23, 2023

BUY
$8.96 - $11.69 $118,451 - $154,541
13,220 New
13,220 $127,000
Q2 2022

Aug 15, 2022

SELL
$8.95 - $12.8 $466,062 - $666,547
-52,074 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$10.05 - $22.48 $25,356 - $56,717
-2,523 Reduced 4.62%
52,074 $645,000
Q4 2021

Feb 14, 2022

BUY
$17.78 - $33.08 $147,200 - $273,869
8,279 Added 17.87%
54,597 $1.24 Million
Q3 2021

Nov 12, 2021

BUY
$10.93 - $23.55 $506,255 - $1.09 Million
46,318 New
46,318 $1.07 Million

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.27B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.